Suppr超能文献

α受体阻滞剂能否促进逆行性肾内手术中输尿管通路鞘的放置?

Can alpha blockers facilitate the placement of ureteral access sheaths in retrograde intrarenal surgery?

作者信息

Erturhan Sakıp, Bayrak Ömer, Şen Haluk, Yılmaz Ali Erdem, Seçkiner İlker

机构信息

Department of Urology, Gaziantep University School of Medicine, Gaziantep, Turkey.

出版信息

Turk J Urol. 2019 Jan 22;45(2):108-112. doi: 10.5152/tud.2019.63373. Print 2019 Mar.

Abstract

OBJECTIVE

To investigate the effects of alpha blocker treatment on the placement of ureteral access sheaths (UAS) during retrograde intrarenal surgery (RIRS).

MATERIAL AND METHODS

This study was a retrospective analysis of prospectively collected data. Patients who underwent RIRS due to renal stones between November 2015 and December 2017 were seperated into two groups. Age, gender, body mass index (BMI), stone size, laterality, hydronephrosis degree, and renal stone density were recorded. Tamsulosin (0.4 mg/day) was prescribed to the study group (n=25) 2 weeks before the operation. The control group (n=25) underwent the operation without any additional treatment. All the operations were performed using a 7.5 Fr flexible ureteroscope and 9.5/11.5 Fr (Cook, Blooming, USA) UAS.

RESULTS

Two patients in the study group were excluded from the study as they suffered from dizziness and retrograde ejaculation. No statistically significant difference was found between the patients in the study group (n=23) and control group (n=25) in terms of age, gender, BMI, stone size, laterality, hydronephrosis, and renal stone density (p=0.470, p=0.536, p=0.456, p=0.102, p=0.555, p=0.732, and p=0.317, respectively). The UAS could be successfully placed on the first attempt in 15 (65.2%) patients in the study group and 11 (44%) patients in the control group during the first attempt itself. Even though the successful UAS placement rate was higher in the study group, no statistically significant values were observed (p=0.141).

CONCLUSION

The data obtained from the present study showed that the use of alpha blockers prior to RIRS did not improve the UAS placement rates. It is considered that studies conducted on more patients might be able to achieve significant values.

摘要

目的

探讨α受体阻滞剂治疗对逆行性肾内手术(RIRS)期间输尿管通路鞘(UAS)置入的影响。

材料与方法

本研究是对前瞻性收集的数据进行的回顾性分析。将2015年11月至2017年12月因肾结石接受RIRS的患者分为两组。记录年龄、性别、体重指数(BMI)、结石大小、侧别、肾积水程度和肾结石密度。研究组(n = 25)在手术前2周服用坦索罗辛(0.4mg/天)。对照组(n = 25)未接受任何额外治疗直接进行手术。所有手术均使用7.5Fr的软性输尿管镜和9.5/11.5Fr(美国布鲁明顿库克公司)的UAS进行。

结果

研究组有2例患者因头晕和逆行射精被排除在研究之外。研究组(n = 23)和对照组(n = 25)在年龄、性别、BMI、结石大小、侧别、肾积水和肾结石密度方面均未发现统计学上的显著差异(p值分别为0.470、0.536、0.456、0.102、0.555、0.732和0.317)。研究组15例(65.2%)患者和对照组11例(44%)患者在首次尝试时即可成功置入UAS。尽管研究组UAS成功置入率较高,但未观察到统计学上的显著差异(p = 0.141)。

结论

本研究获得的数据表明,RIRS术前使用α受体阻滞剂并不能提高UAS置入率。认为对更多患者进行的研究可能会得出有显著意义的结果。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验